ArticleCureus2021
Preoperative Magnetic Resonance Imaging Abnormalities Predict Symptomatic Adjacent Segment Degeneration After Anterior Cervical Discectomy and Fusion.
Article in Cureus, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 2 citations in OpenAlex.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction Anterior cervical discectomy and fusions (ACDFs) are generally limited to the levels causing neurological symptoms, but whether adjacent asymptomatic levels should be included if they demonstrate severe radiographic degeneration is a matter of controversy. We evaluated whether asymptomatic preoperative magnetic resonance imaging (MRI) abnormalities at adjacent levels were predictive of reoperation for symptomatic adjacent-segment degeneration (ASD) after the initial ACDF. Methods We reviewed patients treated with ACDF in 2000-2010 who had MRIs preoperatively and again ≥3 years after the index surgery to evaluate new neurological symptoms. Patients were stratified by ASD severity score, calculated based on MRI features. The associations between preoperative ASD severity score and reoperation for ASD were evaluated with logistic and Cox regressions after adjusting for covariates. Results Of 1038 patients who underwent ACDF, 96 (9%) had MRI evaluation ≥3 years postoperatively (mean follow-up 78 months). Of the 195 adjacent segments evaluated, 14 (7%) were included in subsequent fusion procedures. The 10-year surgery-free survival estimate was 82.7% (73.4-93.2%). After adjusting for covariates, ASD severity scores were predictive of reoperation only for patients with the highest score (hazard ratio [HR] 4.5 [1.0-19.8]) and those with foraminal stenosis (HR 4.2 [.4-12.7]). However, the prevalence of reoperation for ASD in these groups was only 16% and 15%, respectively. Conclusion The prevalence of reoperation for ASD was low for patients who presented with new symptoms ≥3 years after the index ACDF. Our findings do not support including asymptomatic levels in an anterior fusion construct, even if severe MRI abnormalities are present preoperatively.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.